Copyright
©2010 Baishideng.
World J Gastrointest Oncol. Feb 15, 2010; 2(2): 76-84
Published online Feb 15, 2010. doi: 10.4251/wjgo.v2.i2.76
Published online Feb 15, 2010. doi: 10.4251/wjgo.v2.i2.76
Variable | Overall survival | Progression-free survival | ||||
Univariate | Multivariate | Univariate | Multivariate | |||
P value | HR (95% CI) | P value | P value | HR (95% CI) | P value | |
Sex | 0.22 | 0.27 | ||||
Age (< 52 yrvs≥52 yr) | 0.93 | 0.49 | ||||
Performance status (0vs1, 2, or 3) | 0.43 | 0.05 | 0.29 (0.1-0.8) | 0.02 | ||
Previous surgical score (0vs≥1) | 0.78 | 0.11 | ||||
Previous systemic CT | 0.59 | 0.57 | ||||
PCI (≥28vs< 28) | 0.12 | 0.10 | ||||
Completeness of cytoreduction (0/1vs2/3)a | 0.01 | 8.6 (2.1-36.2) | 0.00 | 0.08 | ||
IPHP drug schedule (CDDP + DXvsCDDP + MMC) | 0.36 | 0.98 | ||||
Histological subtype (epithelioidvsbiphasic) | 0.09 | 0.07 | ||||
Mitotic count(< 5vs≥5) | 0.01 | 10.5 (1.9-55.2) | 0.01 | 0.19 | 3.1 (1.1-8.8) | 0.03 |
Nuclear grade (highvslow) | 0.02 | 0.10 |
- Citation: Deraco M, Baratti D, Cabras AD, Zaffaroni N, Perrone F, Villa R, Jocollè J, Balestra MR, Kusamura S, Laterza B, Pilotti S. Experience with peritoneal mesothelioma at the Milan National Cancer Institute. World J Gastrointest Oncol 2010; 2(2): 76-84
- URL: https://www.wjgnet.com/1948-5204/full/v2/i2/76.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v2.i2.76